Literature DB >> 24172599

Response to Rogers et al.

Robert S Stern1.   

Abstract

Mesh：

Year:  2013        PMID： 24172599     DOI： 10.1038/jid.2013.451

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  9 in total

1.  Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting.

Authors:  Leslie S Wilson; Mark Pregenzer; Rituparna Basu; Daniel Bertenthal; Jeanette Torres; Maryam Asgari; Mary-Margaret Chren
Journal:  Dermatol Surg       Date:  2011-12-06       Impact factor: 3.398

2.  Mohs micrographic surgery utilization in the Medicare population, 2009.

Authors:  Matthew R Donaldson; Brett M Coldiron
Journal:  Dermatol Surg       Date:  2012-06-08       Impact factor: 3.398

3.  Use of physicians' services under Medicare's resource-based payments.

Authors:  Stephanie Maxwell; Stephen Zuckerman; Robert A Berenson
Journal:  N Engl J Med       Date:  2007-05-03       Impact factor: 91.245

4.  Properly selected skin cancer treatments are very effective.

Authors:  Howard W Rogers; Eric Armbrecht; Brett M Coldiron; John Albertini; Michel McDonald; Scott M Dinehart; Ali Hendi; George Hruza; Scott W Fosko; Brent R Moody
Journal:  J Invest Dermatol       Date:  2013-11-12       Impact factor: 8.551

5.  Cost effectiveness of Mohs micrographic surgery.

Authors:  Robert S Stern
Journal:  J Invest Dermatol       Date:  2013-05       Impact factor: 8.551

6.  Mohs micrographic surgery for basal cell carcinomas: appropriateness of 'Rotterdam' criteria and predictive factors for three or more stages.

Authors:  S C Flohil; A M J M van Dorst; T Nijsten; H A Martino Neumann; K Munte
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-10-08       Impact factor: 6.166

7.  Rerecurrence 5 years after treatment of recurrent cutaneous basal cell and squamous cell carcinoma.

Authors:  Jeffrey R Hamilton; Rupa Parvataneni; Sarah E Stuart; Mary-Margaret Chren
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

8.  Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up.

Authors:  Klara Mosterd; Gertruud A M Krekels; Fred Hm Nieman; Judith U Ostertag; Brigitte A B Essers; Carmen D Dirksen; Peter M Steijlen; Anton Vermeulen; Ham Neumann; Nicole W J Kelleners-Smeets
Journal:  Lancet Oncol       Date:  2008-11-17       Impact factor: 41.316

9.  Analysis of skin cancer treatment and costs in the United States Medicare population, 1996-2008.

Authors:  Howard W Rogers; Brett M Coldiron
Journal:  Dermatol Surg       Date:  2012-11-30       Impact factor: 3.398
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.